🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Are you a #urologist, #radiationoncologist, or #medicaloncologist? Do you address your #prostatecancer patients to #genetic testing? Do you have access to #Parp-inhibitors? Participate to our global #survey ! 🌎 docs.google.com/forms/d/e/1FAI…

A packed “Aula Lenti” for a terrific #TOP23 kick-off!! Paolo Gontero Marco Oderda Federico Lavagno, MD MolinetteUrology umberto ricardi Massimo Di Maio #prostatecancer #TOPMasterclass Turin 🇮🇹

Marco Oderda on #microwaves at #TOP23 🇮🇹- #highlyprecise-3D fusion : how focal can we go? Focal Therapy Society

🤝🩺 The Société Internationale d’Urologie (SIU) is pleased to support the Università di Torino in helping to disseminate its 3-minute survey to shed light on the current landscape of genetic testing and the use of PARP-inhibitors in different institutions. The answers will be

Robot-assisted PSMA-radioguided surgery to assess surgical margins and nodal metastases in #ProstateCancer patients: Report on three cases using an intraoperative PET-CT specimen imager. #BeyondTheAbstract with Marco Oderda AOU CittàdellaSalute > bit.ly/3IzYnF2 Urology Gold Journal

🆕 Transperineal or Transrectal MRI–targeted Biopsy for #ProstateCancer Detection 🎯 15 🇪🇺 centers - PSM 1301 matched pairs - KOELIS 💡ISUP2(3): 51% vs 45%; OR 1.37 (29% vs 23%; OR 1.38) Institut Jules Bordet Instituut Société Belge d'Urologie European Society of Residents in Urology European Association of Urology (EAU) sciencedirect.com/science/articl…

Read our article European Urology Open Science on inguinal lymphadenctomy for PeCa 😎 👉🏼 OILND vs VEILND ❌ comparable surgical outcomes ✅ VEILND quicker drain removal and less complications 👉🏼VEILND represents a safe technique authors.elsevier.com/sd/article/S26… Paolo Gontero Doç. Dr. Murat Gül Marco Oderda

Day one with Prof. Jean De La Rosette has gone ✅ Such inspiring talks on BPH minimally invasive treatments 🤩👌 This is our team at MolinetteUrology lead by Prof. Paolo Gontero Paolo Destefanis francesco soria Giancarlo Marra Mattia Sibona @ marcoOderda SIU-Urology AOU CittàdellaSalute Università di Torino

Secondary analysis of TITAN trial shows that half of patients with mHSPC treated with apalutamide who experienced radiographic progression developed it without corresponding PSA progression. Great team Jikei Urology Takafumi Yanagisawa Keiichiro Mori Shahrokh F. Shariat sciencedirect.com/science/articl…

A great honor today for our family at MolinetteUrology to have Prof. David Penson Dave Penson with us in Turin! 🇮🇹🇺🇸 Paolo Gontero umberto ricardi Prof.Albera Prof.ssa Cassoni Giancarlo Marra Marco Oderda francesco soria Marco Calandri AOU CittàdellaSalute Università di Torino Amer. Urol. Assn. Vanderbilt Health

Molinette Urology Equipe at ab medica for #SP #Davinci: Paolo Gontero francesco soria Marco Oderda Paolo Destefanis

12-13-14/06 2024 ⤵️ 🔎 Laparoscopy training course in Urology 📍 Università di Torino AOU CittàdellaSalute ✅ Training simulation & live surgeries. We are ready 🙌 Paolo Gontero Lorenzo Repetto Paolo Destefanis Marco Oderda Mattia Sibona Marco Allasia Federico Lavagno, MD CMerzagora MCatalano Società Italiana di Urologia

Clincal and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer by Philip Sutera et al Full article: europeanurology.com/article/S0302-… #MedTwitter #UroSoMe #PCa #ProstateCancer

🧬 Exciting new study shows how Prolaris genomic testing can help men with intermediate-risk #ProstateCancer make better treatment decisions! 📊 Patients recommended for Active Surveillance (AS) by Prolaris were 2x more likely to choose AS and 1.5x more likely to stay on it for 3

Grande partecipazione del pubblico ieri a Bari per NOW or NEVER – Il ruolo dell’#urologo nel trattamento multimodale del #CarcinomaProstatico, tra #Chirurgia e nuove terapie #Ormonali. Responsabili Scientifici Proff. A. Briganti Alberto Briganti e N. Suardi Nazareno Suardi. Docenti:

Happy to speak about #laparoscopic #inguinal #lymphadenectomy!

#TOP24 TURIN ONCOLOGY PROSTATE CANCER MASTERCLASS. FOR WHO IS INTERESTED IN ADVANCING KNOWLEDGE AND SKILLS IN THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER. 🗓️ 13/12 📍Turin, IT 📲 lnkd.in/gzBucbck Paolo Gontero MolinetteUrology Marco Oderda Giancarlo Marra GiuseppeC. Iorio MD

oaepublish.com/webinars/mis.3… Interested in imaging of #radiorecurrent #prostatecancer? Watch this webinar!

Histopathologic features and transcriptomic signatures do not solve the issue of magnetic resonance imaging-invisible #ProstateCancers: a matched-pair analysis. #ProstateCancer invisibility on mpMRI ≠ indolence! A matched-pair study found no histopathologic or transcriptomic

Histopathologic features and transcriptomic signatures do not solve the issue of magnetic resonance imaging-invisible #ProstateCancers: a matched-pair analysis. #ProstateCancer invisibility on mpMRI ≠ indolence! A matched-pair study found no histopathologic or transcriptomic